Abstract
Most people with type 2 diabetes are either overweight or obese, and many are severely so. Although the potential benefits of weight loss for people with type 2 diabetes are profound, weight loss is seldom a major treatment goal, and many diabetes-trained healthcare professionals remain ill-equipped to help patients tackle their obesity. This article examines the current evidence for offering antiobesity drugs or bariatric surgery in the routine management of type 2 diabetes and suggests when and in whom these treatment modalities should be considered.
| Original language | English |
|---|---|
| Number of pages | 0 |
| Journal | Diabetes and Primary Care |
| Volume | 9 |
| Issue number | 2 |
| Publication status | Published - 1 Dec 2007 |
